Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders
Hook, V. Yoon, M. Mosier, C. Ito, G. Podvin, S. Head, B.P. Rissman, R. O'Donoghue, A.J. Hook, G.
Michael Yoon
Yoon Michael
ORCID: 0000-0002-2900-5257
Untargeted mass spectrometry-based metabolomics approach unveils molecular changes in raw and processed foods and beverages 10.1016/j.foodchem.2019.125290
Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders 10.1016/j.bbapap.2020.140428
Assessing the Acceptance of the Pay-For-Performance Model in a Segment of California Pharmacists https://doi.org/10.37901/jcphp17-00011
Differential Neuropeptidomes of Dense Core Secretory Vesicles (DCSV) Produced at Intravesicular and Extracellular pH Conditions by Proteolytic Processing 10.1021/acschemneuro.1c00133
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells 10.1021/acschembio.0c00875
Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions 10.1021/acschembio.1c00138